Technical analysis of PAVmed Inc. (PAVM): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
PAVmed Inc. operates as a U.S.-based medical technology firm. Its principal commercialized products include CarpX, a percutaneous device designed to address carpal tunnel syndrome. Other key offerings are EsoCheck, an esophageal cell collection device vital for the early detection of esophageal adenocarcinoma and Barrett's Esophagus (BE), and EsoGuard, a specialized bisulfite-converted next-generation sequencing DNA assay.
Price Performance
| 1 month | -22.53% |
| 3 months | -24.03% |
| Year-to-date | -40.79% |
| 1 year | -67.68% |
| 3 years | -97.03% |
| 5 years | -99.89% |
52-Week Range
| 52-week High | $28.44 |
| 52-week Low | $3.70 |
| Avg Volume (90d) | 26K |
Technical Indicators
| SMA 50 | $5.06 |
| SMA 200 | $7.54 |
| 30-day Volatility (annualised) | 87.3% |
| Price vs SMA 50 | -22.5% |
| Price vs SMA 200 | -48.0% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $12.87 | |
| 2025-11 | $11.07 | -14.0% |
| 2025-12 | $6.62 | -40.2% |
| 2026-01 | $7.75 | +17.1% |
| 2026-02 | $10.08 | +30.1% |
| 2026-03 | $10.15 | +0.7% |
| 2026-04 | $8.30 | -18.2% |
| 2026-05 | $6.20 | -25.3% |
| 2026-06 | $5.94 | -4.2% |
| 2026-07 | $4.95 | -16.7% |
| 2026-08 | $5.21 | +5.3% |
| 2026-09 | $3.92 | -24.8% |
Price
| Price | $3.92 |
| Market Cap | $25M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 0.70 |
| EV / EBITDA | -2.65 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.49 |
| Current Ratio | 1.19 |